The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus.
暂无分享,去创建一个
[1] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus. , 1997, Advances in cancer research.
[2] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. Zhong,et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.
[4] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[5] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[6] S. Rafii,et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.
[7] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[8] E. Cesarman,et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.
[9] P. Biberfeld,et al. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma , 1995, Nature Medicine.
[10] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[11] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[12] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[13] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[14] M. Kanehisa,et al. A knowledge base for predicting protein localization sites in eukaryotic cells , 1992, Genomics.
[15] Albrecht,et al. Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.
[16] R. Gallo,et al. Pathogenesis of AIDS. , 1992, The Journal of pharmacy and pharmacology.
[17] V. Beral,et al. Cancer, HIV and AIDS. , 1991, Cancer surveys.
[18] R. Desrosiers,et al. Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Gallo,et al. Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.
[20] V. Beral,et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.
[21] R. Desrosiers,et al. Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation , 1989, Journal of virology.
[22] J. Steitz,et al. Four novel U RNAs are encoded by a herpesvirus , 1988, Cell.
[23] G. Heijne. A new method for predicting signal sequence cleavage sites. , 1986 .
[24] A. Bankier,et al. Terminal repetitive sequences in herpesvirus saimiri virion DNA , 1985, Journal of virology.
[25] B. Fleckenstein,et al. Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome , 1976, Journal of virology.
[26] R. Grant,et al. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. , 1996, The Journal of infectious diseases.
[27] D. Watts. Antiviral agents. , 1992, Obstetrics and gynecology clinics of North America.
[28] V. Beral. Epidemiology of Kaposi's sarcoma. , 1991, Cancer surveys.
[29] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[30] B. Giovanella,et al. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. , 1975, Intervirology.